1Q22 Investor Update
COMPANY OVERVIEW
Building Scale, Improving Efficiency and Growing Profitability Across Strategic National Platform
MM
99
US Retail Locations (1)
43%
YOY Topline Revenue
Growth
VE $57M
Q1 2022 Gross Profit
32
US Cultivation &
Manufacturing Facilities (1)
$ $123M
M
Q1 2022 Revenue
46%
Q1 2022 Gross Margin
咱
WW
18
Jurisdictions in
US & Europe
I
+2M
Sqft Cultivation &
Production Capacity(3)
$36B+
2026 TAM in Licensed
US States (2)
Increased footprint and profitability since reported results of Q1 2019,
which included:
150+
Acres Outdoor
Cultivation Capacity (3)
▪ 54 facilities (retail & cultivation) in 15 jurisdictions,
▪ ~500,000sqft cultivation & production capacity
$12.9M in Revenue, $4.4M in Gross Profit and 34% Gross Margin(4)
1)
Pro forma facilities either open or under development; includes facilities where Columbia Care provides consultative services pursuant to the terms of a management services arrangement
2) Estimated Sales figures from BDSA Market Forecast as of May 16 2022, broker research, company estimates
3) Total capacity under existing licenses - additional development may be required to achieve
4) Excluding changes in fair value of biological assets and inventory sold, under IFRS. See Q1 2019 Results.View entire presentation